SYRS - Syros Pharmaceuticals Q4 2022 Earnings Preview
- Syros Pharmaceuticals ( NASDAQ: SYRS ) is scheduled to announce Q4 earnings results on Thursday, March 2nd, before market open.
- The consensus EPS Estimate is -$1.36 (-257.9% Y/Y) and the consensus Revenue Estimate is $3.85M (-95.1% Y/Y).
- Over the last 2 years, SYRS has beaten EPS estimates 38% of the time and has beaten revenue estimates 75% of the time.
For further details see:
Syros Pharmaceuticals Q4 2022 Earnings Preview